120 related articles for article (PubMed ID: 8584886)
21. Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins.
Zoraghi R; Corbin JD; Francis SH
Mol Pharmacol; 2004 Feb; 65(2):267-78. PubMed ID: 14742667
[No Abstract] [Full Text] [Related]
22. Cyclic nucleotides and phosphodiesterases in platelets.
Haslam RJ; Dickinson NT; Jang EK
Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
[No Abstract] [Full Text] [Related]
23. Biochemical characterization of mutants in cyclic nucleotide metabolism showing rhythmic conidiation in Neurospora.
Hasunuma K; Shinohara Y; Funadera K; Furukawa K
Prog Clin Biol Res; 1987; 227A():123-30. PubMed ID: 3037556
[TBL] [Abstract][Full Text] [Related]
24. An Fe2+-dependent cyclic phosphodiesterase catalyzes the hydrolysis of 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate in methanopterin biosynthesis.
Mashhadi Z; Xu H; White RH
Biochemistry; 2009 Oct; 48(40):9384-92. PubMed ID: 19746965
[TBL] [Abstract][Full Text] [Related]
25. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
26. Molecular structure, localization, and possible functions of the myelin-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.
Vogel US; Thompson RJ
J Neurochem; 1988 Jun; 50(6):1667-77. PubMed ID: 2836557
[No Abstract] [Full Text] [Related]
27. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
[TBL] [Abstract][Full Text] [Related]
28. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
Gupta R; Kumar G; Kumar RS
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
[TBL] [Abstract][Full Text] [Related]
29. Cyclic AMP.
Coppe D; Steer ML
Int J Oral Surg; 1978 Feb; 7(1):52-61. PubMed ID: 206518
[TBL] [Abstract][Full Text] [Related]
30. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
Rybalkin SD; Bornfeldt KE
Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
[No Abstract] [Full Text] [Related]
31. Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated.
Reinecke D; Burhenne H; Sandner P; Kaever V; Seifert R
FEBS Lett; 2011 Oct; 585(20):3259-62. PubMed ID: 21920362
[TBL] [Abstract][Full Text] [Related]
32. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
Birk S; Edvinsson L; Olesen J; Kruuse C
Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
[TBL] [Abstract][Full Text] [Related]
34. Cyclic nucleotide phosphodiesterases.
Essayan DM
J Allergy Clin Immunol; 2001 Nov; 108(5):671-80. PubMed ID: 11692087
[TBL] [Abstract][Full Text] [Related]
35. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
[TBL] [Abstract][Full Text] [Related]
36. The effects of flavonoids on cyclic nucleotide phosphodiesterases.
Beretz A; Anton R; Cazenave JP
Prog Clin Biol Res; 1986; 213():281-96. PubMed ID: 3012580
[No Abstract] [Full Text] [Related]
37. Intracellular messengers. Influence of oligodendrocyte substratum adhesion.
Vartanian T; Dawson G; Szuchet S
Ann N Y Acad Sci; 1988; 540():433-6. PubMed ID: 2462818
[No Abstract] [Full Text] [Related]
38. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
[TBL] [Abstract][Full Text] [Related]
39. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
40. Structural similarities and functional differences clarify evolutionary relationships between tRNA healing enzymes and the myelin enzyme CNPase.
Muruganandam G; Raasakka A; Myllykoski M; Kursula I; Kursula P
BMC Biochem; 2017 May; 18(1):7. PubMed ID: 28511668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
